Ranolazine-d8 H-PEG4-CH2COOH CN1N=NN=C1SCC1CS[C@@H]2[C@H](NC(=O)[C@H](O)C3=CC=CC=C3)C(=O)N2C=1C([O-])=O

CN1N=NN=C1SCC1CS[C@@H]2[C@H](NC(=O)[C@H](O)C3=CC=CC=C3)C(=O)N2C=1C([O-])=O

lactose monohydrate

In-situ studies with electronic monitoring of feeding behaviour

The corresponding IC50 values are 0

Resolvin D1 blocks proinflammatory neutrophil migration by regulating actin polymerization

Ranolazine-d8 H-PEG4-CH2COOH CN1N=NN=C1SCC1CS[C@@H]2[C@H](NC(=O)[C@H](O)C3=CC=CC=C3)C(=O)N2C=1C([O-])=ORanolazine d8 (CVT 303 d8) is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 M and 12 M, respectively) without affecting heart rate or blood pressure (BP). Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor. Antianginal agent. Product information CAS Number: 1092804 88 0 Molecular Weight: 435.